Data powered by Alphabet Inc.
Concord Biotech Ltd.
CONCORDBIO
₹ 1,995.55
₹ 62.78
3.24%
Concord Biotech Ltd. Market Sentiment
| Timeline | Returns | Volume |
|---|---|---|
| Daily | 3.24 | 20,534 |
| Weekly | 11.17% | 8,39,970 |
| Monthly | 28.34% | 68,33,091 |
Concord Biotech Ltd. Performance
| Timeline | Daily | Weekly | Monthly |
|---|---|---|---|
| CONCORDBIO | 3.24 | 11.17% | 28.34% |
| Index | - | - | - |
| Peer Avg. | -0.00% | 2.70% | 13.69% |
*Avg of index constituents
Concord Biotech Ltd. Fundamentals
| Timeline | PE | PB | EV/EBIDTA | ROE | ROCE | Div. Yield |
|---|---|---|---|---|---|---|
| CONCORDBIO | - | - | 40.00 | 20.06 | 26.70 | 0.46 |
| Index | 35.44 | 5.98 | 16.81 | 16.99 | 18.41 | 1.19 |
| Peer Avg. | 38.60 | 4.35 | 13.48 | 12.96 | 16.49 | 0.78 |
*Avg of index constituents
Concord Biotech Ltd. Key Metrics
| Metrics | Sales Growth | Profit Growth | ROE | ROCE |
|---|---|---|---|---|
| FY '22-23 | 19.67% | 37.25% | 20.06% | 26.70% |
| FY '21-22 | 15.56% | -25.67% | 16.64% | 21.66% |
| FY '20-21 | 20.42% | 39.28% | 26.60% | 33.01% |
Concord Biotech Ltd. Shareholding Pattern
Promoters : 44.08%
FII : 7.3%
DII : 8.12%
Public : 40.5%
Others : 0%
Concord Biotech Ltd. Profit & Loss
| Metrics | Sales | Expenditure | EBITDA | PAT |
|---|---|---|---|---|
| FY '22-23 | 853.17 | 504.59 | 383.89 | 240.08 |
| FY '21-22 | 712.93 | 439.01 | 297.34 | 174.93 |
| FY '20-21 | 616.94 | 289.01 | 341.74 | 235.34 |
All values are in crores
Concord Biotech Ltd. Peer Comparison
| Metrics | Sales | Expenditure | EBITDA | PAT |
|---|---|---|---|---|
| CONCORDBIO | 853.17 | 504.59 | 383.89 | 240.08 |
| JBCHEPHARM | 2,307.06 | 1,781.39 | 565.10 | 373.52 |
| PPLPHARMA | 7,081.55 | 6,453.31 | 853.35 | -186.46 |
All values are in crores
Concord Biotech Ltd. FAQs
How to Buy Concord Biotech Ltd. Share?
To purchase Concord Biotech Ltd. shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Concord Biotech Ltd. (ticker symbol: CONCORDBIO) on the trading platform provided by your broker and purchase the shares.
What's Concord Biotech Ltd. share price today?
The stock price of Concord Biotech Ltd. as of 13 Sep 2024 is ₹1,995.55
What is the Market Cap of Concord Biotech Ltd.?
Market capitalisation represents the total market value of a company's outstanding shares. As of 13 Sep 2024, Concord Biotech Ltd. (ticker symbol: CONCORDBIO) has a market capitalisation of approximately ₹1,54,10,48,99,302.20
What is the PE and PB ratio of Concord Biotech Ltd.?
Concord Biotech Ltd. Ltd's price-to-book ratio as of 13 Sep 2024 is 0, reflecting the market's valuation compared to its asset value. As of 13 Sep 2024, the trailing twelve months P/E (price-to-earnings) ratio is 0, indicating the market values the company at around ₹0.00 for every ₹1 of earnings
What is the 52 Week High and Low of Concord Biotech Ltd. Share?
Concord Biotech Ltd. Ltd (CONCORDBIO) hit its 52-week high at ₹2,070.26, and its 52-week low at { ₹1,433.94}.